Saint-Sulpice-et-Cameyrac, Nouvelle-Aquitaine, France
A DASH OF FUN WITH SERIOUS RESULTS Hello! I am your go-to accountable colleague for turning business visions into thriving realities, with a grain of fun. With over 25 years of playing withtin the healthcare and MedTech industries, I've mastered the art of transforming complex global markets into hotspots of growth and innovation, always dedicated to building powerhouse multi-experiences and multi-cultures teams and just smashing targets. Here’s a glimpse into my cool journey: Key Skills Strategic thinker: smelling trends and crafting plans for breakfast. Sales Dynamo: From nimble startups to corporate giants, I've exeeded revenues. Team Architect: Creating and leading diverse teams is my hobby, caring and serving my teammates is my purpose. What Colleagues Say. "A visionary leader with a sense of humor who creates a positive long lasting impact" "The head in the cloud, the hands in the grease to get the job done, keeping the eyes on the compass" "Empowers teams to exceed their wildest dreams and then some." The Fun Stuff Languages: Fluent in French, English, and in good vibes. Hobbies: Mentoring future leaders, strategizing over coffee, and dodging pointless meetings with finesse. Contact Location: Bordeaux, France (where the wine flows as smoothly as my ideas). Phone/Email: Just message me and we will talk asap.
Strategy and business games
Serving Pharma companies, Biotech, CDMOs and CROs for equipment, reagents and disposables, for prophylactic and therapeutic vaccines using mRNA technology.
Taregting Cell and Gene Therapy companies and hospital diagnostic wards, my role extended to partnering also with CMOS, CDMOs, and CROs. I catalyzed a rapid transformation within our China operations, laying the foundation for a direct-to-market strategy across Europe. My leadership was pivotal in overhauling our distributor network in China, enhancing geographical reach and customer engagement significantly. This strategic pivot resulted in an impressive 180% increase in year-over-year top-line growth. I also spearheaded the adoption of a novel commercial hybrid model, blending local distributor partnerships with our direct sales team, which propelled our biotech instruments fleet's growth by 87%. Furthermore, this approach effectively tripled our opportunity funnel, far exceeding our budgetary expectations.
I realigned our strategic focus towards cell therapy, embracing both organic and inorganic growth initiatives. Despite navigating a declining global market, this strategic pivot was instrumental in achieving an exceptional growth of $20 million in division sales. This success underscores our ability to innovate and thrive even in challenging market conditions. To revitalize customer engagement, we designed and globally launched a novel series of practitioner webinars on therapeutic apheresis (TA). Initially attracting 40+ attendees, this initiative quickly scaled, drawing between 400 to 1200 participants from its inception, significantly boosting TA usage in markets under competitive pressure from pharmaceuticals across LATAM, Europe, and APAC during the Covid pandemic. Further driving sales, we entered strategic collaborations for cancer therapy in LATAM and Europe, generating an additional $11 million in top-line sales. These partnerships also laid the groundwork for inorganic growth in immunotherapy, with three projects currently under development. As a result of these efforts, we have secured over 85% of the global market share for cell collection for immunotherapy. In recognition of these achievements and my leadership, I was honored as a nominee for the best coach of the year in 2019.
I eliminated unproductive commercial practices, paving the way for a consistent growth trajectory. By implementing innovative commercial strategies, we slashed the time spent on product demonstrations by over 50%, effectively reducing the sales cycle from 6-12 months to just a few months. This strategic overhaul transformed the division, breaking free from four years of stagnant sales and achieving a remarkable 30% increase in sales growth within a year
I initiated the development of innovative processes that enhanced teamwork and regional cross-functional collaboration, propelling the EMEA organization's revenue beyond the $300 million top-line milestone for the first time. By overhauling the budget planning process into a more rigorous, market-based, and bottom-up approach, we achieved about 30% reduction in the effort required to complete these tasks. Additionally, the introduction of annual country plans aligned with a three-year strategic company direction, managed by country heads, resulted in an additional $44 million in top-line sales over my tenure. The implementation of a distributor management program focused on key deliverables also marked the crossing of the $100 million threshold for the first time in 2013. Furthermore, my commitment to coaching and mentorship led three team members to director positions, with two advancing to Vice President roles.